Purpose: A combination of hyperthermia and radiation in the treatment of cancer has been proven to provide better tumor control than radiation administered as a monomodality, without an increase in complications or serious toxicities. Moreover, concurrent administration of hyperthermia and radiation displays synergistic enhancement, resulting in greater tumor cell killing than hyperthermia and radiation delivered separately. The authors have designed a new thermobrachytherapy (TB) seed, which serves as a source of both radiation and heat for concurrent brachytherapy and hyperthermia treatments when implanted in solid tumors. This innovative seed, similar in size and geometry to conventional seeds, will have self-regulating thermal properties.
INTRODUCTION
Hyperthermia, defined as an increase in tissue temperature to [41] [42] [43] [44] [45] [46] • C, is well-established as a clinical cancer treatment modality, most commonly used as an adjuvant treatment. It causes either direct irreversible damage to living cells through protein denaturation, or heat-induced sensitization of cells to ionizing radiation or cytotoxic drugs (chemotherapy) without an increase in normal tissue complications. Various methods have been explored to induce hyperthermia, whether locally, in selected regions of specific organs, or throughout the whole body. [1] [2] [3] [4] [5] Most of the currently available approaches are limited to superficial tissue heating, very limited in their ability to achieve adequate thermal coverage of deep-seated targets, such as tumors within the brain and prostate. Interstitial techniques can potentially heat the tumor to higher temperatures, provide more uniform heat distribution, and improve normal tissue sparing over what is achievable with externally applied hyperthermia.
Several approaches to interstitial hyperthermia have been developed by various groups, with induction heating of ferromagnetic implants being one of the most promising. With this method, the implants consist of a ferromagnetic alloy that produces heat in an oscillating magnetic field of appropriate strength and frequency. [6] [7] [8] [9] This type of implant offers tunability and relative ease of heat delivery, especially if thermal self-regulation is employed via use of a ferromagnetic alloy with a Curie temperature just above the therapeutic temperature range. 10 Permanent interstitial brachytherapy is a common treatment method for early-stage deep-seated solid tumors. It is administered by implantation of small radioactive seeds directly into the tumor, thus delivering a prescribed dose of radiation locally while minimizing damage to nearby normal structures. Brachytherapy also offers the advantage of eliminating daily setup errors and decreasing the impact of organ movement during treatment delivery. 11 Extensive preclinical data demonstrates that adjuvant administration of hyperthermia with radiation offers one of the most efficient enhancements of local and regional cancer control, acting both as a radiation sensitizer and a complementary treatment. [12] [13] [14] Widespread use of this approach was hindered by the failure of hyperthermia delivered in combination with radiation therapy to demonstrate a clear benefit in several clinical trials conducted in the late 1990s. [15] [16] [17] Later analysis proved that the most likely reason for this failure was inadequate thermal coverage of the tumor volume. For example, in the retrospective analysis by Emami et al. of a Phase III study, the authors conclude that only one patient of the 86 who received hyperthermia was considered to have received a sufficient thermal dose. This group suggested that randomized clinical trials of this dual-modality treatment be once again undertaken after substantial technical improvements in heat delivery and dosimetry have been achieved. 17 A number of more recent Phase III clinical trials 18 has reinforced the interest in hyperthermia as an adjuvant therapy providing sensitization for both radiation and chemotherapy.
Combining the standard interstitial brachytherapy approach with hyperthermia, we have designed a source capable of concurrent radiation and heat delivery for treatment of solid tumors, including prostate cancer. 19, 20 The new thermobrachytherapy seed utilizes a sealed 125 I radioactive source coated onto a core of ferromagnetic material (Ni-Cu alloy) that serves as a source of self-regulating hyperthermia when placed in an alternating electromagnetic field. [21] [22] [23] The seed is intended as an alternative to the standard low dose-rate brachytherapy permanent implant seed often used for earlystage prostate adenocarcinoma and other sites of disease. Its use has the potential of addressing some of the shortcomings of other hyperthermia methods, by achieving better temperature uniformity through a denser and more optimized placement of seeds and by avoiding complex and invasive thermometry and feedback loops. 20, 22 Although the size of each of the ferromagnetic seeds is considerably smaller than those used by other groups for hyperthermia alone, the use of a larger number of seeds in our proposed implantation is expected to result in a more uniform thermal coverage. When the dual-modality seeds are implanted to achieve an optimized radiation dose distribution according to LDR permanent implant guidelines, we propose the use of nonradioactive ferromagnetic seeds of the same external dimensions in grid positions not used by thermobrachytherapy seeds. The use of both types of seeds in the same needles during implantation will assure there are enough heat sources to achieve an optimal thermal distribution deep within the tumor volume, as shown later in this paper. Additionally, by adjusting the external magnetic field strength, it is possible to achieve a thermal distribution similar to what was considered an optimized LDR radiation distribution. Moreover, as the thermobrachytherapy seeds provide both heat and radiation, the regions in close proximity to the seeds heated to the temperature of induction of thermotolerance and consequent decrease in direct cell-killing by hyperthermia also receive the highest radiation dose. This complementary improves the efficacy of hyperthermia treatments. [21] [22] [23] One additional advantage of the proposed implementation of the TB seed as a permanent implant is that in the case of local failure of brachytherapy, the already-implanted seeds may be used for sensitization of chemotherapy with hyperthermia. The success of this approach has already been evaluated and documented, as hyperthermia can also be used to induce increased sensitivity to chemotherapy. 18 Alternatively, the implanted seeds can be reused to provide hyperthermia as a monomodality in salvage therapy.
In this study, we present technical aspects of the thermobrachytherapy seed design and address potential problems relevant to its implementation as a prototype. The effect of shielding against the external magnetic field by the titanium shell of the seed, the possibility of damage to the seed due to thermal expansion of its internal components during heating, visibility of the thermobrachytherapy seed in radiographic imaging, and the problem of matching treatment volumes heated to radiosensitivity range with radiation treatment volumes are analyzed, and their effect on the expected performance of the seed is described. The results of experimental work on the effect of annealing on the magnetic properties of the seed core are also presented, identifying this step as crucial in success of implant manufacturing. The ability of seed prototypes to adequately heat a mass of tissue has been evaluated experimentally and compared to modeling results.
MATERIALS AND METHODS

2.A. Principle of operation
The thermobrachytherapy seed works on the principle of ferromagnetic induction heating. When a conductor is placed in an alternating magnetic field, an eddy current is induced near the surface of the conductor, leading to resistive heating of the seed. The power generated by a cylindrical seed of length l and radius a is approximately given by 
Here, ω and H 0 are the frequency (rad/s) and peak intensity of the magnetic field along the axial length of the cylinder, respectively, while μ and σ are the magnetic permeability and electrical conductivity of the ferromagnetic material. When the ferromagnetic material is heated above its Curie temperature (T C ) it becomes paramagnetic, as the magnetic permeability value approaches the permeability of free space . As the generated power is proportional to the square root of μ, heat production decreases above T C . As the temperature decreases, the material becomes ferromagnetic again, increasing the heating power of the thermoseed. This temperature self-regulation is one of the main advantages of the thermobrachytherapy seed design, eliminating the necessity of a feedback-loop type temperature control.
2.B. Ferromagnetic alloys preparation and magnetization measurement
A ferromagnetic alloy with a high magnetic permeability and a sharp Curie transition near 50
• C is ideal for ferromagnetic induction hyperthermia. Achieving these properties in practice involves careful material preparation and a rigorous annealing protocol. We evaluated the influence of slight changes in composition and postpreparation heat treatment regimens on the magnetic properties of ferromagnetic Ni-Cu alloys.
About 3-5 g samples of stoichiometric alloy of composition (1 − x)Ni, (x)Cu (0.28 ≤ x ≤ 0.3) were prepared by the conventional electrical arc melting method in an argon atmosphere using high purity (4N) Ni and Cu elements. The ingots were remelted three or four times in order to achieve good homogeneity in each sample; a mass loss of 0.2%-0.5% was noted. The samples were wrapped in tantalum foil and annealed within a quartz tube under a vacuum generated with a turbomolecular pump. The annealing took place for 24 h at 1000
• C. Still within the vacuum, the samples were allowed to cool down to 40
• C over a period of 2 days. These samples were cut into pieces using a low-speed diamond cutting wheel, and studied in magnetization measurements with a Superconducting Quantum Interference Device (SQUID) magnetometer manufactured by Quantum Design Inc.
2.C. Seed design
The thermobrachytherapy seed is based on one of the standard commercial 125 I seed implants, the BEST Model 2301. long with an outer diameter of 0.8 mm) as the BEST Model 2301 125 I seed, allowing relative ease of prototype implementation from a manufacturing standpoint. The air gap between the titanium shell and the radioactive source is eliminated to permit good thermal contact with the titanium surface. Moreover, by removing the air cavity a greater amount of ferromagnetic material can be employed, resulting in greater heating power of the seed. The manufacturer has verified that it will be possible to fabricate the thermobrachytherapy seed even with the tighter fit of the internal components in the titanium shell.
Construction of the seed starts with fabrication of a cylindrical ferromagnetic core of Ni 0.72 Cu 0.28 alloy. A piece of Ni 0.72 Cu 0.28 alloy is heated in an argon atmosphere and made into a cylindrically shaped wire of diameter 0.44 mm. The wire is cut into 4.54 mm lengths and the ends of each piece are slightly rounded. Each piece is then annealed in high vacuum for 12 h at 1000
• C to yield a ferromagnetic core. An organic matrix impregnated with the 125 I source is coated onto each core, which is then encapsulated by two overlapping layers of titanium welded together. Several prototype seeds were fabricated by BEST Medical International according to the outlined procedure and are used for radiographic studies described later in the paper.
2.D. Effect of magnetic field shielding by the titanium capsule
In the thermobrachytherapy seed, there is a double layer of titanium encapsulating the radioactive iodine and carbon matrix coated on the ferromagnetic core. Conductivity in metals limits the penetration of alternating electromagnetic fields to a penetration (skin) depth layer, given by
Here, I 0 and I(x) are the intensities of the electromagnetic field at the surface and at depth x in the medium and δ is the penetration depth.
The skin depth of a conducting medium of electrical conductivity σ and magnetic permeability μ can be calculated by
Here, ω is the angular frequency of the alternating field. As titanium is an electric conductor, it has a certain skin depth at a given frequency. If the skin depth is comparable to the thickness of the titanium wall, there will be considerable attenuation of the magnetic field experienced by the ferromagnetic core, decreasing power generation. We studied the shielding effect of the titanium layer on the magnetic field within the seed.
2.E. Thermal expansion of the thermobrachytherapy seed
In order to evaluate the structural rigidity of the seed, consisting of several different materials, we analyzed the effect of an increase in temperature from room temperature to the temperature of the seed when exposed to an alternating magnetic field. Due to thermal expansion, an increase in temperature changes the size of each component of the seed. If the thermal expansion of the inner components is sufficiently greater than that of the outer titanium capsule, the capsule will be subjected to excessive internal stress, and could potentially crack, leaking radioactive material. Therefore, for safe implementation of the thermobrachytherapy seed for cancer treatment it must be verified that any thermal expansion will be well within the tolerance limit of the outer titanium capsule. The expansion of the ferromagnetic Ni-Cu core, the graphite (organic matrix coated on the core), and the outer titanium capsule was calculated for an increase of temperature from 20
• C to 60
• C, using the linear thermal expansion equation with the greatest dimension of each component.
2.F. Radiographic properties of the thermoseed
For dosimetric verification purposes, the seeds must be clearly visible in CT images. Modern brachytherapy seeds incorporate high atomic number components to permit postimplant CT verification. The new thermobrachytherapy seed uses the Ni-Cu alloy in the core, which has a lower effective atomic number than tungsten. We have compared radiographic images of the prototype thermobrachytherapy seed, fabricated by BEST Medical International, with those of the standard BEST Model 2301 seed. We took CT images and plain X-ray images of both types of seeds. For the CT images the seeds were put in the pelvic region of an anthromorphic RANDO phantom manufactured by The Phantom Laboratory and scanned. For X-ray imaging, the thermobrachytherapy and BEST seeds were sandwiched between two rectangularly shaped water-equivalent bolus material slabs of thickness 1 cm each.
2.G. Computational evaluation of the irradiated and radiosensitized volumes
In order to assure the efficacy of the TB seed as a source of both radiation and heat, we conducted computational evaluations of volumetric dose coverage for both modalities. A modeled water phantom was irradiated to a prescription radiation dose and heated to the temperature range of induction of radiosensitivity for two-and three-dimensional implantation patterns of seeds. Spatial distributions of the maximum temperature reached in a cylindrical water phantom during a hyperthermia session were obtained via COMSOL Multiphysics 3.5, a finite element analysis partial differential equation solver software package. The corresponding radiation dose distributions were calculated by the Monte Carlo software package Monte Carlo N-Particle Version 5 (MCNP5). Isodose coverage and generated cumulative dose-volume histograms (DVH) for both temperature and radiation dose were compared.
Two-and three-dimensional implantation patterns were considered. For the two-dimensional case, a 4 × 4 array of TB seeds was placed in a 15-cm diameter cylindrical water phantom, with the axes of the seeds perpendicular to the implantation plane and a separation distance of 1 cm along an axis between centers of neighboring seeds. A radiation spatial distribution was generated from a two-dimensional tally array in MCNP5, and the tally values normalized so that the average dose 0.5 cm from the edges of the implant was considered to be 100% of a "prescription" dose. A corresponding temperature distribution was obtained for the same seed and phantom geometry in COMSOL 3.5, with the magnetic field strength at the center of the implant adjusted for a particular magnetic field frequency until the 42
• C isothermal line (considered to be the threshold temperature of induction of radiosensitivity) corresponded with the 100% radiation isodose line. For this particular study, the target was considered to consist of water at the center of a simulated water phantom, and no blood perfusion was modeled.
A similar pattern was evaluated for a three-dimensional array of TB seeds, consisting of three parallel layers of 4 × 4 two-dimensional arrays of seeds, placed 1 cm apart. As with the two-dimensional case, the distance between centers of seeds was 1 cm along the seeds' axes. A planning target volume (PTV) was defined as a right rectangular prism 0.5 cm from the centers of seeds along the edges of the implant. A three-dimensional grid of tallies was defined throughout this PTV in MCNP5, and was normalized such that the 100% isodose line covered 90% of the volume of the PTV. The tallies were then tabulated to yield a cumulative DVH of radiation dose within the PTV.
The same three-dimensional array was modeled in COMSOL 3.5, with the same magnetic field parameters found to be optimal for the two-dimensional case. A temperature volume histogram was calculated by finding the volume of isothermal lines surrounding the implant, and subtracting the volume of any part of the isothermal line that extended beyond the PTV. These histograms were compared to evaluate the correspondence between the volumes radiosensitized to hyperthermia and exposed to doses near the prescribed dose.
2.H. Preliminary induction heating experiment
Preliminary experiments of induction heating were performed with pieces of the ferromagnetic Ni-Cu wire of nearly the same dimensions as standard BEST 2301 seeds. The oscillating magnetic field required for induction heating is generated in the induction heating coil via an alternating current in the coil. We used a coil with 6 turns and a diameter of approximately 6 cm for our preliminary experimental study. This coil is hollow to permit cooling via cold water continuously run through it.
For the experiment we used sliced ham of approximately 1 cm thickness as a tissue-mimicking phantom. Ni-Cu wires were cut into 5-mm pieces, and 16 of them were implanted into the phantom in a 4 × 4 pattern. The distance between adjacent wire pieces was approximately 1 cm, and the pieces were oriented such that their axes were perpendicular to the surface of the phantom and parallel to the predominant magnetic field direction.
For visualization of the temperature distribution on the surface of the phantom, a Fluke Ti100 thermal imager was used. This thermal imager relies on a microbolometer array to provide a two-dimensional thermal map of the surface of an object, by measuring its emission in the 7.5-14 μm range of the infrared region of the electromagnetic spectrum. An Omega Engineering HHTFO-101 fiber optic thermometer was also used to obtain the internal temperature of the phantom with time. This thermometer is compatible with the experimental setup as it contains no metal components near the point of measurement and therefore does not generate heat when placed inside the coil. Temperature as a function of time was recorded at the surface of the phantom with the thermal imager, as well as at the center of the implant plane within the phantom with the fiber optic thermometer. The experiment was also modeled in COMSOL using a constant-temperature approximation for the seed prototypes to obtain a theoretical temperature-versus-time curve to compare with the experimental data.
RESULTS
3.A. Magnetization measurement
The magnetization as a function of temperature M(T) for unannealed and annealed samples of Ni 0.72 Cu 0.28 alloy is presented in Fig. 2 . One can see the difference in magnetic behavior between annealed and unannealed samples. As the temperature decreased from 100
• C, the magnetization of the alloys increased, indicating the presence of a second-order phase transition (paramagnetic to ferromagnetic phase) at the Curie temperature (T C ) . The annealed sample shows a clear Curie transition at a temperature of about 50
• C. However, the unannealed sample does not have a clear transition point. This indicates that heat treatment has a strong influence on the structure and magnetic properties of the Ni-Cu alloy. Annealing causes atomic diffusion and leads to homogenization of the samples, reaching a unique phase corresponding to a nominal composition. Any mechanical stretching of the annealed alloy changes its magnetic properties by altering the interatomic distances, and appropriate thermal treatment, including annealing and quenching of the alloy, is essential to regain its original magnetic properties.
The T C of Ni 1−x Cu x alloys changes drastically with small changes in composition. With an increase in concentration of Cu, the T C decreases rapidly. The variation of T C with percentage Cu concentration is plotted in Fig. 3 . The data show that an alloy with a Cu concentration of about 28% has a T C of about 52
• C. If the Cu concentration increases to 28.5%, the Curie temperature decreases to 41
• C. From the linear fit in Fig. 3 , the rate of change of T C is estimated to be −13.7
• C/% of Cu concentration. Our observed T C values of the Ni 1−x Cu x alloys are slightly different than those of the published data. 8, 25 This difference in the T C is likely due to a different thermal treatment of the alloys. It has been reported previously 26 that varying the annealing and cooling times changes the T C values.
3.B. Effect of magnetic field shielding by the titanium capsule
The skin depths of materials used in construction of the seed are estimated using Eq. (3). The relative permeability of titanium is taken to be unity (nonmagnetic), and the electrical conductivity is 2.4 × 10 6 Siemens/m. Figure 4 shows the penetration depth for a frequency range of 50-500 kHz. The penetration depth of titanium is about 1.46 mm at a frequency of 50 kHz and 0.46 mm at 500 kHz. Our intended working magnetic field frequency is from 100 to 300 kHz. The average value of the penetration depth in this range of frequencies is about 0.76 mm, an order of magnitude larger than the thickest portion of the titanium encapsulation wall. Figure 4 also presents the variation of the fractional attenuation of the external magnetic field by the titanium capsule with the frequency of the magnetic field. The values are estimated taking the thickness of the titanium capsule as 0.08 mm. We calculate that the fraction of field transmitted through the wall is 0.95 at a magnetic field frequency of 50 kHz, and the attenuation increases with increase of the frequency. At a frequency of 500 kHz the fraction of the magnetic field that transmits the titanium wall is about 0.82. The average fraction of the magnetic field that transmits the titanium capsule is about 0.9 for our working frequency range of 100 to 300 kHz. Table I summarizes the parameters used for the thermal expansion calculation of all three seed components. The coefficients of thermal expansion are values obtained from available literature. [27] [28] [29] The fairly narrow interval of working temperatures • C) results in very small relative changes in length (strain) of each material component, specifically, 5.6 × 10 −4 , 1.7 × 10 −4 , and 3.4 × 10 −4 for the Ni-Cu ferromagnetic core, the organic matrix coated on the core, 
3.C. Thermal expansion of thermobrachytherapy seed
3.D. Radiographic properties of the thermoseed
Radiographic images of the seeds are presented in Fig. 5 . CT images of the thermobrachytherapy seed and the BEST Model 2301 seed [ Fig. 5(a) ] show that the new seed can be seen as clearly as the unmodified commercial 2301 model. The plain X-ray images [ Fig. 5(b) ] also verify similar radiographic properties of the two seeds. We note that the physical length of the thermobrachytherapy prototype seed in the present implementation is a little larger than that of the commercial seed, as evident from close inspection of the plain radiograph. Despite the slight difference in length, a comparison of the radiographic images shows that the newly developed thermobrachytherapy seed preserves the radiographic properties of the standard seed and thereby permits postimplant seed position verification via CT images.
3.E. Computational evaluation of the irradiated and radiosensitized volumes
A qualitative comparison of the radiation and thermal dose distributions for the two-dimensional case reveals that when the 42
• C isothermal line is made to correspond with the 100% radiation isodose line by adjusting the magnetic field strength for a particular field frequency (125 kHz), the area heated above 44
• C receives approximately 130% or more of the prescription radiation dose (Fig. 6 with solid and dashed lines corresponding to radiation and thermal isodoses, respectively).
A comparison of the radiation and temperature distributions of the three-dimensional case was done by comparing the radiation DVH and temperature-volume histogram (TVH) obtained from MCNP5 and COMSOL 3.5, respectively. As shown in Fig. 7 for this arrangement, the "shoulder" of the TVH occurs slightly below 42
• C, indicating that almost all of the volume of the PTV is exposed to at least the minimum temperature that induces radiosensitivity. About 44% of the volume of the PTV is exposed to temperatures of 44
• C or greater; the same percentage of the PTV volume receives 177% of the radiation prescription dose. Finally, 6% of the PTV volume receives 208% of the radiation prescription dose and is heated to 46
• C. While the difference between local dose deposition by radiation and heat transport in thermal dose means that these volumes do not correspond completely, this study provides strong evidence that regions of the target tissue heated to thermotolerance and consequent loss of direct cell killing during the next hyperthermia treatment also receive radiation doses well above the prescription, a complementary effect. This effect is expected to help compensate for the noncomplementarity of high thermal doses in high dose rate regions near the seeds. The magnetic induction parameters may be modified to change the amount of coverage if it is deemed radiobiologically desirable. More work is necessary to determine the most advantageous heating parameters to produce the highest possible tumor control probability. FIG. 7 . Generated cumulative dose volume histograms for radiation and temperature in the PTV defined for the three-dimensional seed distribution discussed in the text. Thermal data is shown by the points and the radiation dose volume histogram is given by the solid line.
3.F. Preliminary induction heating experiment
Before starting the preliminary induction heating experiment, the temperature of the phantom with 5 mm-long pieces of Cu-Ni wire implanted in a 4 × 4 two-dimensional pattern was about 21
• C, slightly below the room temperature (background) of 22
• C. As soon as the induction heating system was turned on the temperatures of the wire segments and the ham phantom began to increase. The temperature of the phantom surface exceeded 40
• C after 5 min of heating, and reached 51
• C after 30 min. The equilibrium temperature of the phantom surface was 52
• C after 1 h of heating. Figure 8 shows images of the slice and coil taken by the thermal imager after 30 s (a) and 30 min (b) of heating, while Fig. 9 gives temperature increase for the entire period of heating. This experiment clearly demonstrates the feasibility of ferromagnetic induction heating with a commercial induction heater and the ability of the Ni-Cu alloy to reach a hyperthermiainducing temperature within a reasonable time and to keep a piece of tissue at a constant temperature. We note that the size of our seeds in the present study is substantially smaller than seeds used in ferromagnetic induction heating experiments published previously. 6, 7, 15, 16, 30, 31 A slight difference between temperature measured at the phantom surface (IR camera) and in the middle of implantation plane (FO thermometer) in Fig. 9 is due to ambient air cooling of the phantom surface. The close agreement between the measured and modeled data from COMSOL for both the temperature rise and final temperature distribution validates our modeling effort.
DISCUSSION
The primary intended use of this seed is prostate brachytherapy and hyperthermia, as a modification of the ubiquitous low dose-rate permanent implant brachytherapy treatment. Since that treatment typically involves about 100 seeds implanted into a deep-seated target and not easily treated by other hyperthermia methods, it is ideally suited their recommended use of small seed spacing and in placing a sufficient number of seeds up to the periphery of the target to achieve a more uniform thermal distribution. 32 We, therefore, expect our approach to alleviate the problem of insufficient thermal coverage of the target expressed by previous authors. 17, 33 In the review of the randomized Phase III clinical trial of radiation therapy alone versus radiation and hyperthermia for recurrent or persistent tumors by Emami et al., 17 the difficulty in achieving a sufficient hyperthermia treatment was identified as the primary cause of the negative result. The authors report that for 86 patients in the radiation therapy with hyperthermia arm, only one received sufficient hyperthermia. Among the conditions for a sufficient hyperthermia treatment the authors identify criteria for volume of the target heated, minimum temperature parameters achieved during treatment, and typical spacing between heat sources, all of which we believe our implant design may improve. The first criterion, the ratio of volume of tissue implanted with seeds to the volume of the target, will be met since a typical prostate LDR implantation consists of seeds at least up to the edge of the prostatic capsule. They may also be expected to improve the minimum temperature parameters, as temperature achieved in a hyperthermia treatment is typically limited by the maximum tissue temperature reached. Distributing the sources of heat from relatively few, larger hyperthermia seeds to more numerous thermobrachytherapy and hyperthermia-only seeds is expected to produce more uniform thermal coverage. Lastly, an implantation following typical LDR brachytherapy planning guidelines for radiation with additional hyperthermiaonly seeds would result in a seed-to-seed spacing of about 1 cm. This spacing, notably smaller than interseed spacings achieved in previous work, will help avoid cold spots in the target tissue, as multiple authors suggest that a high implantation density is needed for this reason. 6, 32 In order to take maximum advantage of the hyperthermiainduced radiosensitivity effect described throughout the literature, and to avoid the effect of thermotolerance in the target tissue, we propose a treatment regimen consisting of one or two 30-60 min administrations of hyperthermia per week for the first month after the implant. The use of hyperthermia early after implantation takes advantage of the higher dose rate early in treatment. While a small fraction of the total radiation dose would be delivered during the hyperthermia treatments themselves, dose from the seeds would continue to be delivered as radiosensitivity induced by a treatment decays away with time. As radiosensitivity is considered to be primarily the result of tissue reoxygenation, it may be treated as existing over a timeframe similar to that of redevelopment of hypoxia. This timeframe, which may vary depending on the tumor in question, is nevertheless considerably longer than the treatment itself. 34, 35 In fact, quantification of reoxygenation in the tumor 24 h after the first hyperthermia session has been proposed as a useful marker in gauging the expected success of a hyperthermia regimen. 35 Moreover, other putative contributing effects to radiosensitivity, for example, acidosis within the heated volume and sensitivity to heat of cells in the S phase of the cell cycle, known to be the phase least sensitive to radiation, are not correctly considered by assuming that heightened cell killing occurs only during the hyperthermia treatments themselves. 36 A number of authors have demonstrated that a considerable thermal enhancement ratio (TER) over radiation treatments alone is achievable with hyperthermia treatments delivered with only a few of the fractions of radiation. 35, 37 Nevertheless, the thermal enhancement ratio of hyperthermia with low dose-rate brachytherapy has received little attention in the literature compared to other forms of radiation therapy, 37 and awaits further research. The thermal modeling of the seeds conducted in COMSOL takes into account the physical properties of the seeds and approximates the biological properties of tissue by assuming a constant metabolic rate and a blood perfusion rate in the tissue that is either constant or zero. While we consider these parameters approximately constant once the seeds and surrounding tissue have nearly reached their equilibrium temperatures, both physical parameters are expected to fluctuate, especially in the early stages of the heating process. In particular, normal tissue greatly increases its perfusion rate in response to hyperthermia, though cancerous tissue with its typically poorly developed and chaotic vasculature is not nearly as capable of doing so. 6, 7 We have previously published COMSOL-computed data on temperature distributions in a simulated phantom for arrangements of seeds at varying tissue perfusion rates, showing the relative effect of different perfusion rates on the final temperature distribution. 8 Thoroughly modeling the changes in perfusion rate and metabolic heat production for simulated tissue and analyzing their effects on thermal dose is considered to be achievable with an appropriate level of vasculature modeling, 38, 39 and is a future goal of this research.
CONCLUSIONS
We have evaluated several aspects of practical implementation of a newly developed thermobrachytherapy seed, capable of concurrent delivery of radiation and heat for adjuvant treatment of solid tumors. Identification of critical issues in the production of the ferromagnetic alloy seed core, verification of structural integrity of the seed under thermal expansion, estimation of magnetic field penetration, and proof of adequate radiographic properties have been invaluable in moving forward into the prototype manufacturing stage. In addition, radiation and temperature distributions were computationally found for seed arrangements with 1 cm seed-to-seed spacing, and the relative fractions of tissue exposed to differing clinical doses of radiation and heated to temperatures of hyperthermia compared in 3D space. Since this spacing is closer than that of a typical LDR brachytherapy plan, additional hyperthermiaonly seeds will be implanted, helping avoid low-temperature spots in the target tissue. Our proposed modification of the standard LDR brachytherapy implant procedure is technically simple to implement in a clinical setting; such a high-density seed spacing has the potential of overcoming the difficulties encountered by previous researchers and producing adequate thermal coverage of the target.
Finally, a preliminary experimental study of ferromagnetic induction heating with a commercially available system demonstrates the practicality of hyperthermia delivery with specialized brachytherapy seeds and the thermal selfregulating property of the Ni-Cu alloy for seed sizes smaller than those previously reported in the literature. Good agreement with the simulation results validates our computational model.
